Stroke Treatment Academic Industry Roundtable: The Next Generation of Endovascular Trials.
about
Time Course of Evolution of Disability and Cause-Specific Mortality After Ischemic Stroke: Implications for Trial Design.Optimized Management of Endovascular Treatment for Acute Ischemic Stroke.ASPECTS Large Vessel Occlusion, and Time of Symptom Onset: Estimation of Eligibility for Endovascular Therapy.Stroke Cytoprotection: Can Repeating History with New Expectations Really Be the Path to Success in Stroke Research?Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke.Seeing Is Believing: Headway27 as a Highly Visible and Versatile Microcatheter with Ideal Dimensions for Stroke Thrombectomy
P2860
Stroke Treatment Academic Industry Roundtable: The Next Generation of Endovascular Trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Stroke Treatment Academic Indu ...... ration of Endovascular Trials.
@en
type
label
Stroke Treatment Academic Indu ...... ration of Endovascular Trials.
@en
prefLabel
Stroke Treatment Academic Indu ...... ration of Endovascular Trials.
@en
P2093
P2860
P1433
P1476
Stroke Treatment Academic Indu ...... ration of Endovascular Trials.
@en
P2093
David S Liebeskind
Gregory W Albers
STAIR IX Consortium
Tudor G Jovin
P2860
P304
P356
10.1161/STROKEAHA.116.013578
P407
P577
2016-09-01T00:00:00Z